Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
201
-
Total 13F shares, excl. options
-
61M
-
Shares change
-
-1.13M
-
Total reported value, excl. options
-
$2.93B
-
Value change
-
+$23.6M
-
Put/Call ratio
-
0.81
-
Number of buys
-
112
-
Number of sells
-
-88
-
Price
-
$48.03
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q4 2019
261 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q4 2019.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61M shares
of 79.2M outstanding shares and own 77.05% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (5.47M shares), VANGUARD GROUP INC (5.44M shares), BlackRock Inc. (4.91M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.04M shares), RTW INVESTMENTS, LP (3.83M shares), FMR LLC (2.42M shares), STATE STREET CORP (2.34M shares), GREAT POINT PARTNERS LLC (1.75M shares), ORBIMED ADVISORS LLC (1.73M shares), and JANUS HENDERSON GROUP PLC (1.49M shares).
This table shows the top 201 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.